Federation des caisses Desjardins du Quebec
KRYS icon

Federation des caisses Desjardins du Quebec’s Krystal Biotech KRYS Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$644K Buy
1,733
+1,683
+3,366% +$503K ﹤0.01% 1268
2026
Q1 		$12.9K Hold
50
– – ﹤0.01% 2234
2025
Q4 		$12.3K Hold
50
– – ﹤0.01% 2191
2025
Q3 		$8.83K Hold
50
– – ﹤0.01% 2305
2025
Q2 		$6.87K Hold
50
– – ﹤0.01% 2175
2025
Q1 		$9.02K Hold
50
– – ﹤0.01% 1998
2024
Q4 		$7.83K Hold
50
– – ﹤0.01% 1955
2024
Q3 		$9.1K Hold
50
– – ﹤0.01% 1911
2024
Q2 		$9.18K Hold
50
– – ﹤0.01% 1832
2024
Q1 		$8.9K Hold
50
– – ﹤0.01% 1841
2023
Q4 		$6.2K Hold
50
– – ﹤0.01% 1859
2023
Q3 		$5.8K Hold
50
– – ﹤0.01% 1880
2023
Q2 		$5.87K Hold
50
– – ﹤0.01% 1875
2023
Q1 		$4K Buy
+50
New +$3.93K ﹤0.01% 1961

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's KRYS Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Krystal Biotech (KRYS) stake by 3,366% in Q2 2026, buying an estimated $503K and bringing the position to 1,733 shares worth $644K. The position accounts for ﹤0.01% of the portfolio, ranked #1268.

Federation des caisses Desjardins du Quebec first reported a position in KRYS in Q1 2023 and has held it in 14 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 1,733 shares of Krystal Biotech worth $644K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 1,683 Krystal Biotech shares in Q2 2026, an estimated $503K.
  • Krystal Biotech made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1268 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Krystal Biotech in Q1 2023 and has held it in 14 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.